Log In
BCIQ
Print this Print this
 

IMU-838

  Manage Alerts
Collapse Summary General Information
Company Immunic AG
DescriptionOrally available DHOHD inhibitor
Molecular Target Dihydroorotate dehydrogenase (DHODH)
Mechanism of ActionDihydroorotate dehydrogenase (DHODH) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today